VERAPAMIL

Verapamil Adverse Events Reported to the FDA Over Time

How are Verapamil adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Verapamil, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Verapamil is flagged as the suspect drug causing the adverse event.

Most Common Verapamil Adverse Events Reported to the FDA

What are the most common Verapamil adverse events reported to the FDA?

Completed Suicide	1048 (4.65%)
Hypotension	581 (2.58%)
Bradycardia	520 (2.31%)
Drug Interaction	398 (1.76%)
Overdose	303 (1.34%)
Dizziness	297 (1.32%)
Drug Ineffective	250 (1.11%)
Dyspnoea	244 (1.08%)
Drug Toxicity	233 (1.03%)
Nausea	230 (1.02%)
Death	229 (1.02%)
	Show More
Cardiac Arrest	221 (.98%)
Vomiting	200 (.89%)
Atrial Fibrillation	197 (.87%)
Metabolic Acidosis	196 (.87%)
Asthenia	195 (.86%)
Suicide Attempt	190 (.84%)
Intentional Overdose	176 (.78%)
Hyperkalaemia	166 (.74%)
Renal Failure	163 (.72%)
Renal Failure Acute	163 (.72%)
Headache	158 (.7%)
Cardiogenic Shock	152 (.67%)
Malaise	143 (.63%)
Syncope	142 (.63%)
Loss Of Consciousness	138 (.61%)
Atrioventricular Block Complete	136 (.6%)
Blood Pressure Increased	136 (.6%)
Somnolence	135 (.6%)
Shock	134 (.59%)
Fatigue	128 (.57%)
Hypertension	126 (.56%)
Blood Pressure Decreased	121 (.54%)
Chest Pain	115 (.51%)
Atrioventricular Block	108 (.48%)
Medication Error	106 (.47%)
Pulmonary Oedema	102 (.45%)
Cardiac Failure	100 (.44%)
Palpitations	99 (.44%)
Abdominal Pain	98 (.43%)
Cough	96 (.43%)
Heart Rate Decreased	95 (.42%)
Constipation	92 (.41%)
Hallucination	90 (.4%)
Hyperhidrosis	90 (.4%)
Poisoning	90 (.4%)
Depressed Level Of Consciousness	89 (.39%)
Blood Creatinine Increased	87 (.39%)
Diarrhoea	87 (.39%)
Cardio-respiratory Arrest	86 (.38%)
Confusional State	86 (.38%)
Pyrexia	84 (.37%)
Respiratory Arrest	84 (.37%)
Nodal Rhythm	82 (.36%)
Anuria	81 (.36%)
Dehydration	79 (.35%)
Hyperglycaemia	77 (.34%)
Oedema Peripheral	76 (.34%)
Multiple Drug Overdose	75 (.33%)
Atrioventricular Block First Degree	73 (.32%)
Cardiomegaly	71 (.31%)
Rhabdomyolysis	71 (.31%)
Coma	69 (.31%)
Feeling Abnormal	69 (.31%)
Multiple Drug Overdose Intentional	69 (.31%)
Hypokalaemia	68 (.3%)
Anxiety	67 (.3%)
Fall	67 (.3%)
Circulatory Collapse	66 (.29%)
Condition Aggravated	65 (.29%)
Pruritus	65 (.29%)
Pulse Absent	65 (.29%)
Depression	64 (.28%)
Multi-organ Failure	63 (.28%)
Orthostatic Hypotension	61 (.27%)
Arrhythmia	60 (.27%)
Blood Creatine Phosphokinase Increa...	60 (.27%)
Heart Rate Increased	60 (.27%)
Hypoxia	60 (.27%)
Blood Glucose Increased	59 (.26%)
Haemodialysis	58 (.26%)
Oedema	58 (.26%)
Sinus Bradycardia	58 (.26%)
Decreased Appetite	56 (.25%)
Abdominal Discomfort	55 (.24%)
Arthralgia	55 (.24%)
Toxic Epidermal Necrolysis	55 (.24%)
Atrioventricular Block Second Degre...	54 (.24%)
Hepatitis	54 (.24%)
Intentional Drug Misuse	53 (.24%)
Blood Pressure Inadequately Control...	52 (.23%)
Presyncope	52 (.23%)
Tachycardia	52 (.23%)
Acute Respiratory Distress Syndrome	50 (.22%)
General Physical Health Deteriorati...	50 (.22%)
Alanine Aminotransferase Increased	49 (.22%)
Off Label Use	49 (.22%)
Hypersensitivity	48 (.21%)
Renal Impairment	48 (.21%)
Hypoglycaemia	47 (.21%)
Myocardial Infarction	47 (.21%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Verapamil, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Verapamil is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Verapamil

What are the most common Verapamil adverse events reported to the FDA?

Cardiac Arrhythmias	2126 (9.43%)
Suicidal And Self-injurious Behavio...	1264 (5.6%)
Neurological	1234 (5.47%)
Decreased And Nonspecific Blood Pre...	956 (4.24%)
Medication Errors	909 (4.03%)
Cardiac And Vascular Investigations	846 (3.75%)
Gastrointestinal Signs	832 (3.69%)
Therapeutic And Nontherapeutic Effe...	783 (3.47%)
Respiratory	774 (3.43%)
Renal Disorders	547 (2.43%)
Epidermal And Dermal Conditions	512 (2.27%)
	Show More
Chemical Injury And Poisoning	416 (1.84%)
Electrolyte And Fluid Balance Condi...	390 (1.73%)
Heart Failures	324 (1.44%)
Muscle	296 (1.31%)
Acid-base	272 (1.21%)
Fatal Outcomes	247 (1.1%)
Infections - Pathogen Unspecified	245 (1.09%)
Lower Respiratory Tract Disorders	229 (1.02%)
Gastrointestinal Motility And Defec...	223 (.99%)
Hepatic And Hepatobiliary	223 (.99%)
Coronary Artery	219 (.97%)
Hepatobiliary	215 (.95%)
Headaches	212 (.94%)
Cardiac Disorder Signs	203 (.9%)
Metabolic, Nutritional And Blood Ga...	179 (.79%)
Myocardial	168 (.74%)
Renal And Urinary Tract Investigati...	168 (.74%)
Injuries	167 (.74%)
Hematology Investigations	165 (.73%)
Skin Appendage Conditions	155 (.69%)
Musculoskeletal And Connective Tiss...	148 (.66%)
Water, Electrolyte And Mineral	140 (.62%)
Anxiety Disorders	136 (.6%)
Vascular	132 (.59%)
Vascular Hypertensive	132 (.59%)
Glucose Metabolism Disorders	130 (.58%)
Movement Disorders	126 (.56%)
Central Nervous System Vascular	120 (.53%)
Physical Examination Topics	120 (.53%)
Deliria	116 (.51%)
Allergic Conditions	115 (.51%)
Body Temperature Conditions	111 (.49%)
Toxicology And Therapeutic Drug Mon...	111 (.49%)
Enzyme	109 (.48%)
Urinary Tract Signs	109 (.48%)
Joint	104 (.46%)
Psychiatric	102 (.45%)
Arteriosclerosis, Stenosis, Vascula...	96 (.43%)
Disturbances In Thinking	96 (.43%)
Bacterial Infectious	88 (.39%)
Sleep Disorders	84 (.37%)
Therapeutic Procedures And Supporti...	83 (.37%)
Skin Vascular Abnormalities	81 (.36%)
Hematological And Lymphoid Tissue T...	79 (.35%)
Vision	79 (.35%)
Appetite And General Nutritional	78 (.35%)
Anemias Nonhemolytic And Marrow Dep...	77 (.34%)
Gastrointestinal Hemorrhages	76 (.34%)
Angiedema And Urticaria	75 (.33%)
Depressed Mood Disorders	74 (.33%)
Ocular Neuromuscular	74 (.33%)
Seizures	74 (.33%)
White Blood Cell	68 (.3%)
Bronchial Disorders	67 (.3%)
Upper Respiratory Tract Disorders	67 (.3%)
Lifestyle Issues	62 (.27%)
Product Quality Issues	56 (.25%)
Eye	55 (.24%)
Lipid Analyses	52 (.23%)
Oral Soft Tissue Conditions	52 (.23%)
Embolism And Thrombosis	51 (.23%)
Inner Ear And Viiith Cranial Nerve	50 (.22%)
Procedural And Device Related Injur...	50 (.22%)
Neuromuscular	49 (.22%)
Cardiac Valve	46 (.2%)
Dental And Gingival Conditions	45 (.2%)
Bone, Calcium, Magnesium And Phosph...	43 (.19%)
Bone And Joint Injuries	41 (.18%)
Gastrointestinal Conditions	41 (.18%)
Gastrointestinal Vascular Condition...	39 (.17%)
Sexual Function And Fertility	39 (.17%)
Mental Impairment	37 (.16%)
Platelet	37 (.16%)
Pulmonary Vascular	37 (.16%)
Viral Infectious	37 (.16%)
Gastrointestinal Ulceration And Per...	34 (.15%)
Coagulopathies And Bleeding Diathes...	32 (.14%)
Gastrointestinal Inflammatory Condi...	30 (.13%)
Pleural	30 (.13%)
Vascular Hemorrhagic	30 (.13%)
Bone Disorders	29 (.13%)
Nephropathies	29 (.13%)
Neurological, Special Senses And Ps...	29 (.13%)
Peripheral Neuropathies	29 (.13%)
Cardiac Therapeutic Procedures	28 (.12%)
Protein And Chemistry Analyses	26 (.12%)
Salivary Gland Conditions	25 (.11%)
Gastrointestinal Stenosis And Obstr...	24 (.11%)
Bone And Joint Therapeutic Procedur...	23 (.1%)
Musculoskeletal And Connective Tiss...	23 (.1%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Verapamil, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Verapamil is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.